Existing clients

Log in to your client extranet for free matter information, know-how and documents.

Client extranet portal

Staff

Mills & Reeve system for employees.

Staff Login

Katharine Robinson

Principal Associate

What can I do for you

Katharine advises clients in a variety of sectors, with a particular focus on technology and life sciences. She specialises in mergers and acquisitions, venture capital, joint ventures and restructuring transactions, as well as general corporate governance and shareholder and board advisory matters. Katharine works with clients who are based locally, nationally and internationally.

Supporting your ambitions

Katharine's experience includes: 

  • Assisting on the sale of Iontas Limited for founding shareholder, Dr John McCafferty, to FairJourney Biologics (backed by GMO Capital).
  • Advising the shareholders of Delta Financial Systems on their sale to Bravura Solutions
  • Acting for the majority shareholders of Biocrucible, a Cambridge based molecular diagnostics company, on their sale to Sapphiros.
  • Providing legal advice to the shareholders of Raleigh Adhesive Coatings Ltd on its sale to Advanced Medical Solutions Group plc
  • Advising FactSet in connection with a $15m Series A funding round in Accelex Technology
  • Acting for Optalysys on a £21m Series A funding round led by Lingotto (an investment management company owned by Exor N.V.), imec.xpand and Northern Gritstone.
  • Supporting open source platform Gravitee.io on its $11 million funding round
  • Working with long-standing client IQ Capital since joining the firm in 2020 on a series of investments including investments under the Government backed Future Fund

What do others say

Katharine has previously been recognised in The Legal 500 as a ‘Rising Star’.

What our clients say about us

  • I think Mills & Reeve are a wonderful firm. The support they have provided to us in a really difficult area has been brilliant, collaborative and commercially minded. The team were absolutely wonderful and a joy to work with. Amazing advice and support and a real collaborative effort with us. I can't thank them enough for getting us through some really tough times and doing so with an amazing can-do attitude.
  • They are friendly, fast, always available and always on top of the game. I tend to judge my legal team against the other side's legal team and never doubt Mills & Reeve is the better of the two.
  • All interactions have been very clear. Responses to questions have always been very swift and unambiguous. Our company, and my family, have used various services in Mills & Reeve with the same level of satisfaction.
  • I value the fact that Mills & Reeve are recognised as a good place to work in the UK Best Companies survey. This aligns with the values of our business and means that Mills & Reeve can share what is required to achieve this status with our business.

As many clients will testify, too many lawyers deliver the required legal expertise but fail to deliver an outstanding client experience. Which is why we always listen to our clients and constantly ask ourselves what we can do to deliver the results you expect.

You expect a close and attentive working relationship, with a lawyer that is responsive and available when you need them. You also want clear, pragmatic and commercial advice tailored to your needs, and transparency and certainty on costs. We completely agree. That’s why every day, through our culture and approach we are committed to delivering the exceptional results and service our clients expect of us.

Related sectors and services

  • AgriTech
  • Biotechnology and pharmaceuticals
  • Business start-ups and spin-outs
  • Capital markets (Corporate law)
  • Corporate law
  • Health and care
  • Health and care: M&A and other corporate transactions
  • Health tech
  • Investment funds
  • Shareholder activism
  • Life sciences
  • Medical devices, diagnostics and medtech
  • Mergers, acquisitions and disposals
  • Owner managed and family businesses
  • Private equity
  • Technology
  • Venture capital and equity investments